David Inglefield

Popular Topics

Intellectual Property Food, Drugs, Healthcare, Life Sciences

David Inglefield’s articles from Oblon, McClelland, Maier & Neustadt, L.L.P are most popular:

within Intellectual Property topic(s)
in South America, North America and Asia

DETAILS

United States

+1 703 413 3000

AUTHORS CONTENT

Eye Therapies, LLC. v. Slayback Pharma, LLC: How Prosecution History Can Alter Phrase Interpretation

United States IP

US Synthetic Corp. v. International Trade Commission: Safeguarding Structure And Property Limitations In Composition-of-Matter Claims

United States Healthcare

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More